Skip to main content

letter

. 1995 Jul;40(1):105–106. doi: 10.1111/j.1365-2125.1995.tb04548.x

Treatment of Parkinson's disease in a patient with acute intermittent porphyria.

PMCID: PMC1365041 PMID: 8527261

105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Blackwell A., Fox A., Phillips I., Barlow D. Metronidazole in treatment of non-specific vaginitis. Clinical and microbiological findings in ten patients given 2 grams of metronidazole. Scand J Infect Dis Suppl. 1983;40:103–106. [PubMed] [Google Scholar]
Blackwell A., Fox A., Phillips I., Barlow D. Metronidazole in treatment of non-specific vaginitis. Clinical and microbiological findings in ten patients given 2 grams of metronidazole. Scand J Infect Dis Suppl. 1983;40:103–106. [PubMed] [Google Scholar]
MAUZERALL D., GRANICK S. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem. 1956 Mar;219(1):435–446. [PubMed] [Google Scholar]
Strand L. J., Meyer U. A., Felsher B. F., Redeker A. G., Marver H. S. Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria. J Clin Invest. 1972 Oct;51(10):2530–2536. doi: 10.1172/JCI107068. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES